Third International Conference on Metals and Genetics

第三届国际金属与遗传学会议

• 批准号: 6863351
• 负责人: Max Costa
• 金额: $ 1.5万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-06-01 至 2005-05-24
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6863351
• 关键词: Third; International; Conference; Metals; Genetics

DESCRIPTION (provided by applicant) This conference will bring together experts in structural biology, bioinorganic chemistry and environmental toxicology of copper, zinc, iron, nickel and arsenic. Translational research relating to the genetics and clinical aspects of metabolic disease involving abnormalities of the handling of these metals will be emphasized. As the third in a series of conferences devoted to advances in research relating to metals and genetics held at the Hospital for Sick Children in Toronto since 1994, this conference will focus on the most recent research developments. Issues relating to the environmental contamination and child health in the developing world will receive special attention. This conference will also pay tribute to the research interests and scientific contributions of Bibudhendra Sarkar, Emeritus Professor of Biochemistry at the University of Toronto, a pioneer in the field of bioinorganic chemistry and translational research relating to metabolic disease. This conference is highly relevant to the SBRP because it address key issues relating to environmental health sciences and, by bringing together a diverse group of scientists and clinician-investigators, it will foster multidisciplinary, translational research. Extended abstracts of the conference will be published in The Journal of Clinical Biochemistry.

描述（由申请人提供） 这次会议将汇集铜，锌，铁，镍和砷的结构生物学，生物无机化学和环境毒理学的专家。 将强调与代谢疾病的遗传学和临床方面有关的转化研究，涉及处理这些金属的异常。 自1994年以来，这是一系列专门致力于与金属和遗传学有关的研究进展的第三个会议，自1994年以来，在多伦多的病童医院举行的金属和遗传学方面，这次会议将重点介绍最新的研究发展。 与发展中国家的环境污染和儿童健康有关的问题将受到特别关注。 这次会议还将向多伦多大学生物化学名誉教授Bibudhendra Sarkar的研究兴趣和科学贡献致敬，多伦多大学是生物促进化学和转化研究领域的先驱。 这次会议与SBRP高度相关，因为它解决了与环境健康科学有关的关键问题，并通过将一群科学家和临床医生评估者组合在一起，它将培养多学科的转化研究。 会议的扩展摘要将发表在《临床生物化学杂志》上。